ARTICLE | Distillery Therapeutics
Autoimmune disease; renal
August 1, 2018 8:09 PM UTC
Patient sample and mouse studies suggest inhibiting CAMK4 could help treat lupus nephritis, focal segmental glomerulosclerosis (FSGS) and other podocytopathies. In kidney samples from lupus nephritis ...
BCIQ Company Profiles
BCIQ Target Profiles